USPTO serial 79293806
MILTENYI BIOTEC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 20, 2021
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MILTENYI BIOTEC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial, scientific and diagnostic purposes, including medical diagnostic purposes, namely, biological tissue cultures; chemical products, namely, chemical additives for use in separation processes for biological materials; reagents for cell separation, labeling reagents, reagents, media, substances and ingredients for the preparation of media, all for commercial and scientific purposes and for the use in medical laboratories; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of materials, especially of chemical and biological material for non-medical purposes; reagents with magnetic beads for research purposes; antibody reagents other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments; reagents for processing of biological material, especially tissue, bone marrow, cells, blood and its components for use in research and other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, in biological treatment processes and in the biotechnology industry | ACTIVE | — |
| 002 | Dyestuffs; colorants; all especially for pharmaceutical, medical, or scientific purposes | ACTIVE | — |
| 005 | Pharmaceutical, medical and veterinary preparations for the early recognition or characterization of diseases; reagents, media, materials and ingredients for the preparation of media, all for medical or veterinary purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials, reagents with magnetic beads, antibody reagents, all for medical or veterinary purposes; buffer solutions and reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; culture media, cell culture media, diagnostic reagents and preparations for medical and veterinary purposes; freezing media, contrast agents, contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical products, namely, pharmaceutical preparations for the cellular therapy treatment of cancer, autoimmunity, infection and inflammation and other tissue-based diseases, immunological, dermatological and neurological diseases; chemical, biological and biochemical preparations for therapeutic purposes, namely, diagnostic preparations made from chemicals and biochemicals for medical purposes for the treatment of cancer and biological preparations for the therapeutic treatment of cancer, autoimmunity, dermatology, neurological and cardiovascular diseases | ACTIVE | — |
| 009 | Scientific, optical and measuring apparatus and instruments, namely, laboratory apparatus and instruments for the separation, analysis, processing and cultivation of biological material; apparatus for recording, transmission or reproduction of images; data processors; downloadable computer software for controlling and managing of blood and blood elements information; downloadable computer software for use in operating equipment for the separation, analysis, processing and cultivation of biological material; scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions; laboratory equipment, in particular, cytometer for measuring physical and chemical properties of cells and other particles in suspensions | ACTIVE | — |
| 010 | Medical apparatus for magnetic cell separation for medical purposes; tubing sets for medical purposes; medical diagnostic apparatus in the nature of columns for blood analysis for medical purposes; sacks, bags, sheets, tubes and connectors for medical, scientific or biotechnological purposes, in particular for tissue and blood collection for cryopreservation; surgical apparatus and instruments for medical, biotechnological and scientific purposes; dialysis machines for medical use; apheresis machines for medical use; veterinary apparatus and instruments for medical, dental, and veterinary use; dental apparatus and instruments for use in general surgery; medical apparatus and instruments for use in general surgery | ACTIVE | — |
| 016 | Plastic materials for packaging, namely, bags and foils for the cryopreservation of biological and biochemical material, especially cellular material for biological and medical research and therapy | ACTIVE | — |
| 017 | Sacks, bags, sheets, tubes and joints of rubber, gutta-percha, rubber, semi-processed plastics, for medical, scientific or biotechnological purposes, especially for cryopreservation; plastic films for the manufacture of the aforesaid goods; hoses, hose assemblies and fittings, especially for medical, scientific or biotechnological purposes | ACTIVE | — |
| 039 | Biological and biochemical storage, especially cryopreserved material for medical, scientific and biotechnological purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design of medical and laboratory equipment; industrial laboratory analysis and research services in the field of Biology and medicine; design and development of computer hardware and software for the analysis, all of the aforementioned services for and in connection with the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy | ACTIVE | — |
| 044 | Services of medical, pharmaceutical or biotechnological laboratories, medical and pharmaceutical services, namely, services of a medical and pharmaceutical laboratory, in particular in connection with the manufacture of cell therapeutic agents, cell compounds, cell preparation, cellular medicines, the selection, stimulation, activation of cells, as well as the manufacture of kits or reagents, medical services, in particular the field of extracorporeal plasma therapy; medical treatment services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks owned by Miltenyi Biotec B.V. & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 017
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MILTENYI BIOTEC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 13, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 19, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 19, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 20, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 4, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 19, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 14, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 14, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 26, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 26, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 26, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 26, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 24, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 3, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 3, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 3, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 3, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 3, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 3, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 16, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 16, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 30, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 29, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 17, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |